ArticleOncology letters2020

Early response of bone metastases can predict tumor response in patients with non-small-cell lung cancer with bone metastases in the treatment with nivolumab.

Eiji Nakata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.